Nothing says a feverish new listing quite like leveraged products lining up before the opening-week confetti has settled. Anthropic priced its IPO at $83 on November 18, raised roughly $81.3 billion, then opened Nasdaq trading at $111.50 on November 19. That is an enormous gap between IPO price and first trade, and it tells investors the obvious thing: plenty of appetite was already packed into this story.
A Red-Hot Debut Meets a Fast Trading Tool
Leverage Shares by Themes plans to launch its 2X Long Anthropic Daily ETF on Cboe this Monday, November 23. The fund will seek 200% of Anthropic's daily performance before fees and expenses. That last word matters more than the flashy 2X label. This is not a shortcut to owning a piece of Anthropic. It is a trading instrument built for investors who have a very specific view of what the stock may do over a single session.
ANT itself is the straightforward route: buy shares in a brokerage account during normal market hours, use a market or limit order, and own the common stock. Investors arriving after the IPO allocation window are simply buying in the open market, where the price can be nowhere near $83. Frankly, anybody treating that original IPO price as a reliable anchor after a $111.50 opening is begging to get emotionally attached to a number that no longer controls anything.
The notes contain one small wording wrinkle worth flagging. They say Anthropic began trading on November 19, while a later FAQ says its Class A shares are “expected” to trade under the same ticker. The meaningful stated facts are clear enough: the company priced at $83, opened at $111.50, and is presented as trading on Nasdaq. Still, new-listing materials can get assembled in a hurry, and investors should always verify the live quote, listing status, and product availability in their own brokerage screen rather than relying on promotional copy.
Daily Means Daily, Not “Until I Feel Better”
The fund's whole design rests on a daily reset. If Anthropic rises 5% in a day, a 2X long fund would target roughly a 10% gain before fees and expenses. If the stock falls 5%, the intended hit is roughly 10%. But over multiple days, compounding and volatility can make the result differ sharply from twice the stock's cumulative move. It is not a footnote. It is the machinery.
That distinction gets ignored whenever a hot name hits the tape. Traders see a giant IPO, a popular artificial-intelligence narrative, and a product promising amplified exposure, then they mentally convert it into “more upside.” Markets have punished that lazy translation for decades. A stock can finish a choppy stretch little changed, yet a daily leveraged ETF can still take damage as it resets through alternating moves.
ANUU is a daily exposure tool, not a substitute for holding Anthropic shares over the long haul.
The stated expense ratio is 0.75% for the 2X long offering. That is not the only cost worth watching. Bid-ask spreads, brokerage commissions where applicable, trading timing, and the behavior of the derivatives used to create exposure all matter. Fresh ETFs can also have limited operating history and thinner early trading conditions. Nobody should assume a newly launched vehicle will trade with the smoothness of a giant, seasoned fund on day one.
The Risk Is Not Academic
The prospectus-style warnings are blunt because the math can be brutal. A decline of more than 50% in Anthropic stock during one trading day could wipe out the full principal value of the 2X long fund. That is an extreme move, sure, but “extreme” is not the same as impossible in a newly public company carrying huge expectations. Big debut premiums invite big opinion changes when earnings, guidance, regulation, competition, or simple valuation nerves hit.
- Buy the common stock if the goal is direct ownership and a longer-term thesis.
- Use a limit order if price discipline matters more than immediate execution in a volatile new listing.
- Treat the 2X fund as an actively monitored daily trade, not a tucked-away portfolio position.
- Know the exit plan before entering, because leverage makes hesitation expensive.
Three Products, Three Different Jobs
Monday's scheduled launch also includes a 2X short fund and a 1X short fund, with expense ratios of 0.75% and 0.99%, respectively. Those vehicles broaden the menu for active traders, but they do not make the situation simpler. Inverse exposure has its own compounding problems, and a sharp upward move can produce severe losses. The short products are not a casual hedge for somebody who has not read how daily rebalancing works.
My read is pretty plain. Anthropic's debut has created a legitimate trading event, and these funds give sophisticated investors more ways to express a view. But the first sensible question is not whether leverage can juice a winner. It is whether the investor can explain, in plain English, why the position exists, how long it will be held, and where the loss gets cut. If those answers are mushy, stick with the common shares—or sit on your hands. Both are better choices than learning daily leverage the hard way.